Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -27.20% and Operating profit at -207.52% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 2.33 times
- The company has been able to generate a Return on Equity (avg) of 1.88% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pesticides & Agrochemicals
INR 13 Cr (Micro Cap)
NA (Loss Making)
31
0.00%
2.75
-12.69%
2.36
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-25-2014
Risk Adjusted Returns v/s 
Returns Beta
News

Phyto Chem (India) Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Phyto Chem (India), a player in the Pesticides & Agrochemicals sector, has experienced a revision in its market assessment driven primarily by changes in technical indicators, while its fundamental financial metrics continue to reflect challenges. This article analyses the recent shifts across quality, valuation, financial trends, and technical parameters to provide a comprehensive view of the company’s current standing.
Read More
Phyto Chem (India) Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Phyto Chem (India), a player in the Pesticides & Agrochemicals sector, has experienced a notable revision in its market evaluation following recent developments across technical indicators, financial trends, valuation metrics, and overall quality assessment. This article analyses the factors influencing the current market perspective on the stock, highlighting key data points and contextualising its performance relative to broader market benchmarks.
Read More
Phyto Chem (India) Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Phyto Chem (India), a player in the Pesticides & Agrochemicals sector, has experienced a notable shift in market assessment driven primarily by changes in technical indicators, despite ongoing challenges in its financial performance and valuation metrics. This article analyses the recent developments across quality, valuation, financial trends, and technical parameters that have influenced the company's current market standing.
Read More Announcements 
Results-Financial Results For SEP 30 2025 (Submission Of Unaudited Financial Results Of The Company For The Second Quarter And Half-Year Ended 30Th September 2025 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations 2015-Regarding
14-Nov-2025 | Source : BSEIn furtherance to the Board meeting notice dated 06-11-2025 we wish inform you that at the meeting of Board of Directors of M/s.Phyto Chem (India) Limited held today i.e. on 14-11-2025 the Board has inter-alia considered and approved the unaudited financial results for the second quarter and half year ended 30-09-2025. The said unaudited financial results were reviewed by the audit committee and their after approved by the Board. Pursuat Regulation 33 of the SEBI(LODR) Regulations 2015 statement showing the unaudited financial results for the second quarter and half year ended on 30-09-2025 along with limited review report issued by the statutory auditors is attached herewith. The meeting commenced at 04:00PM and concluded at 08:15PM.
Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Regarding
14-Nov-2025 | Source : BSEPursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 14th November 2025 the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the Second Quarter and half- year ended 30th September 2025. The meeting commenced at 04:00 P.M. and concluded at 08:15 P.M. This is for your information and record.
Board Meeting Intimation for Intimation Of Board Meeting To Consider Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2025 Under Regulation 29 Of SEBI (LODR) Regulations 2015 - Regarding.
06-Nov-2025 | Source : BSEPhyto Chem India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Friday the 14th day of November 2025 at 04:00 P.M. at the Corporate office of the Company at No.8-3-229/23 First Floor Thaherville Yousufguda Checkpost Hyderabad - 500045 Telangana state inter-alia to consider and take on record the Unaudited Financial Results of the Company for the Second Quarter and half year ended 30th September 2025. In this connection as per the Companys Code of Conduct for Prohibition of Insider Trading the Trading Window for dealing in the securities of the Company is closed for all the Directors/ Officers/ Designated Employees of the Company from 01-10-2025 and will open after 48 hours of the announcement and intimation of the Results by the Company to the Stock Exchange on 14-11-2025. This communication has already been circulated to all the Directors/ Officers/ Designated Employees of the Company.
Corporate Actions 
No Upcoming Board Meetings
Phyto Chem (India) Ltd has declared 10% dividend, ex-date: 25 Sep 14
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 2 Schemes (0.19%)
Held by 0 FIIs
Nayudamma Yarlagadda (7.87%)
Andhra Pradesh Industrial Development Corporation Limited (4.63%)
49.36%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -0.23% vs -39.39% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -609.09% vs 168.75% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024
Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -12.11% vs -33.96% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 109.82% vs -1,730.00% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -4.93% vs -44.66% in Mar 2024
YoY Growth in year ended Mar 2025 is 70.27% vs -1,613.64% in Mar 2024






